VioQuest Pharmaceuticals, Inc.
VOQP
$0.00
$0.000.00%
OTC PK
| 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | 06/30/2007 | |
|---|---|---|---|---|---|
| Net Income | -5.55% | -28.30% | -31.69% | 26.21% | 23.05% |
| Total Depreciation and Amortization | 22.08% | 23.61% | 41.27% | 172.73% | 250.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -74.00% | -55.65% | -33.83% | -80.39% | -66.33% |
| Change in Net Operating Assets | -106.19% | 5.36% | 369.04% | 467.17% | 441.52% |
| Cash from Operations | -26.20% | -19.04% | -9.67% | -3.16% | 5.60% |
| Capital Expenditure | 88.45% | 87.28% | 81.69% | -5.08% | -202.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 98.85% | 89.45% | 32.59% | -44.22% |
| Cash from Investing | 867.42% | 687.67% | 702.31% | 503.46% | 48.91% |
| Total Debt Issued | -76.66% | -- | -- | -- | -- |
| Total Debt Repaid | -64.60% | -152.80% | -- | 0.00% | 62.21% |
| Issuance of Common Stock | -- | -- | -- | -52.90% | -52.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.77% | -- | -- | -- | -- |
| Cash from Financing | -48.11% | 9.02% | -13.68% | -9.14% | -16.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -500.16% | 60.95% | 27.62% | 191.02% | -57.01% |